Antimicrobial peptides explained

Antimicrobial peptides (AMPs), also called host defence peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antimicrobials which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria,[1] enveloped viruses, fungi and even transformed or cancerous cells.[2] Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Structure

Antimicrobial peptides are a unique and diverse group of molecules, which are divided into subgroups on the basis of their amino acid composition and structure.[3] Antimicrobial peptides are generally between 12 and 50 amino acids. These peptides include two or more positively charged residues provided by arginine, lysine or, in acidic environments, histidine, and a large proportion (generally >50%) of hydrophobic residues.[4] [5] [6] The secondary structures of these molecules follow 4 themes, including i) α-helical, ii) β-stranded due to the presence of 2 or more disulfide bonds, iii) β-hairpin or loop due to the presence of a single disulfide bond and/or cyclization of the peptide chain, and iv) extended.[7] Many of these peptides are unstructured in free solution, and fold into their final configuration upon partitioning into biological membranes. The peptides contain hydrophilic amino acid residues aligned along one side and hydrophobic amino acid residues aligned along the opposite side of a helical molecule. This amphipathicity of the antimicrobial peptides allows them to partition into the membrane lipid bilayer. The ability to associate with membranes is a definitive feature of antimicrobial peptides,[8] [9] although membrane permeabilization is not necessary. These peptides have a variety of antimicrobial activities ranging from membrane permeabilization to action on a range of cytoplasmic targets.

Type characteristic AMPs - Anionic peptides rich in glutamic and aspartic acids Maximin H5 from amphibians, dermcidin from humans - Linear cationic α-helical peptideslack in cysteine Cecropins, andropin, moricin, ceratotoxin and melittin from insects, Magainin, dermaseptin, bombinin, brevinin-1, esculentins and buforin II from amphibians, CAP18 from rabbits, LL37 from humans - Cationic peptide enriched for specific amino acidrich in proline, arginine, phenylalanine, glycine, tryptophanabaecin and drosocin, apidaecin, diptericin, and attacin from insects, prophenin from pigs, indolicidin from cattle. - Anionic/cationic peptides forming disulfide bondscontain 1~3 disulfide bond

Activities

The modes of action by which antimicrobial peptides kill microbes are varied,[10] and may differ for different bacterial species.[11] Some antimicrobial peptides kill both bacteria and fungi, e.g., psoriasin kills E. coli and several filamentous fungi.[12] The cytoplasmic membrane is a frequent target, but peptides may also interfere with DNA and protein synthesis, protein folding, and cell wall synthesis.[10] The initial contact between the peptide and the target organism is electrostatic, as most bacterial surfaces are anionic, or hydrophobic, such as in the antimicrobial peptide Piscidin. Their amino acid composition, amphipathicity, cationic charge and size allow them to attach to and insert into membrane bilayers to form pores by ‘barrel-stave’, ‘carpet’ or ‘toroidal-pore’ mechanisms. Alternately, they may penetrate into the cell to bind intracellular molecules which are crucial to cell living.[13] Intracellular binding models includes inhibition of cell wall synthesis, alteration of the cytoplasmic membrane, activation of autolysin, inhibition of DNA, RNA, and protein synthesis, and inhibition of certain enzymes. In many cases, the exact mechanism of killing is not known. One emerging technique for the study of such mechanisms is dual polarisation interferometry.[14] [15] In contrast to many conventional antibiotics these peptides appear to be bactericidal[2] instead of bacteriostatic. In general the antimicrobial activity of these peptides is determined by measuring the minimal inhibitory concentration (MIC), which is the lowest concentration of drug that inhibits bacterial growth.[16]

AMPs can possess multiple activities including anti-gram-positive bacterial, anti-gram-negative bacterial, anti-fungal, anti-viral, anti-parasitic, and anti cancer activities. A big AMP functional analysis indicates that among all AMP activities, amphipathicity and charge, two major properties of AMPs, best distinguish between AMPs with and without anti-gram-negative bacterial activities.[17] This implies that being AMPs with anti-gram-negative bacterial activities may prefer or even require strong amphipathicity and net positive charge.

Immunomodulation

In addition to killing bacteria directly they have been demonstrated to have a number of immunomodulatory functions that may be involved in the clearance of infection, including the ability to alter host gene expression, act as chemokines and/or induce chemokine production, inhibiting lipopolysaccharide induced pro-inflammatory cytokine production, promoting wound healing, and modulating the responses of dendritic cells and cells of the adaptive immune response. Animal models indicate that host defense peptides are crucial for both prevention and clearance of infection. It appears as though many peptides initially isolated as and termed "antimicrobial peptides" have been shown to have more significant alternative functions in vivo (e.g. hepcidin[18]). Dusquetide for example is an immunomodulator that acts through p62, a protein involved in toll like receptor based signalling of infection. The peptide is being examined in a Phase III clinical trial by Soligenix (SGNX) to ascertain if it can assist in repair of radiation-induced damage to oral mucosa arising during cancer radiotherapy of the head and neck.[19]

Mechanisms of action

Antimicrobial peptides generally have a net positive charge, allowing them to interact with the negatively charged molecules exposed on bacteria and cancer cell surfaces, such as phospholipid phosphatidylserine, O-glycosylated mucins, sialylated gangliosides, and heparin sulfates. The mechanism of action of these peptides varies widely but can be simplified into two categories: membranolytic and non-membranolytic antimicrobial peptides.[20] The disruption of membranes by membranolytic antimicrobial peptides can be described by four models:

Several methods have been used to determine the mechanisms of antimicrobial peptide activity.[11] [22] [24] In more recent years, X-ray crystallography has been used to delineate in atomic detail how the family of plant defensins rupture membranes by identifying key phospholipids in the cell membranes of the pathogen.[25] [26] Human defensins have been thought to act through a similar mechanism, targeting cell membrane lipids as part of their function. In fact human beta-defensin 2 have now been shown to kill the pathogenic fungi Candida albicans through interactions with specific phospholipids.[27] From the computational point of view, Molecular Dynamics simulations can provide detailed information about the structure and dynamics of the peptide-membrane interactions, including the orientation, conformation, and insertion of the peptide in the membrane, as well as specific peptide interactions with lipids, ions and solvent.[28]

Methods Applications
Microscopyto visualize the effects of antimicrobial peptides on microbial cells
Atomic emission spectroscopyto detect loss of intracellular potassium (an indication that bacterial membrane integrity has been compromised)
Fluorescent dyesto measure ability of antimicrobial peptides to permeabilize membrane vesicles
Ion channel formationto assess the formation and stability of an antimicrobial-peptide-induced pore
Circular dichroism and orientated circular dichroismto measure the orientation and secondary structure of an antimicrobial peptide bound to a lipid bilayer
Dual polarization interferometryto measure the different mechanisms of antimicrobial peptides
Solid-state NMR spectroscopyto measure the secondary structure, orientation and penetration of antimicrobial peptides into lipid bilayers in the biologically relevant liquid-crystalline state
Neutron and X-ray diffractionto measure the diffraction patterns of peptide-induced pores within membranes in oriented multilayers or liquids
Molecular dynamics simulationsto study the molecular behaviour and search for specific peptide-lipid interactions
Mass spectrometryto measure the proteomic response of microorganisms to antimicrobial peptides

Therapeutic research and use

Antimicrobial peptides have been used as therapeutic agents; their use is generally limited to intravenous administration or topical applications due to their short half-lives. As of January 2018 the following antimicrobial peptides were in clinical use:[29]

Activity beyond antibacterial functions

AMPs have been observed having functions other than bacterial and fungal killing. These activities include antiviral effects, but also roles in host defence such as anticancer functions and roles in neurology.[30] This has led to a movement for re-branding AMPs as "Host-defence peptides" to encompass the broad scope of activities AMPs can have.[31]

Anticancer properties

Some cecropins (e.g. cecropin A, and cecropin B) have anticancer properties and are called anticancer peptides (ACPs). Hybrid ACPs based on Cecropin A have been studied for anticancer properties.[32] The fruit fly Defensin prevents tumour growth, suspected to bind to tumour cells owing to cell membrane modifications common to most cancer cells, such as phosphatidylserine exposure.[33]

Antibiofilm properties

Cecropin A can destroy planktonic and sessile biofilm-forming uropathogenic E. coli (UPEC) cells, either alone or when combined with the antibiotic nalidixic acid, synergistically clearing infection in vivo (in the insect host Galleria mellonella) without off-target cytotoxicity. The multi-target mechanism of action involves outer membrane permeabilization followed by biofilm disruption triggered by the inhibition of efflux pump activity and interactions with extracellular and intracellular nucleic acids.[34]

Other research

Recently there has been some research to identify potential antimicrobial peptides from prokaryotes,[35] aquatic organisms such as fish,[36] [37] and shellfish,[38] and monotremes such as echidnas.[39] [40]

Selectivity

In the competition of bacterial cells and host cells with the antimicrobial peptides, antimicrobial peptides will preferentially interact with the bacterial cell to the mammalian cells, which enables them to kill microorganisms without being significantly toxic to mammalian cells.[41]

With regard to cancer cells, they themselves also secrete human antimicrobial peptides including defensin, and in some cases, they are reported to be more resistant than the surrounding normal cells.Therefore, we cannot conclude that selectivity is always high against cancer cells.[42] [43]

Factors

There are some factors that are closely related to the selectivity property of antimicrobial peptides, among which the cationic property contributes most. Since the surface of the bacterial membranes is more negatively charged than mammalian cells, antimicrobial peptides will show different affinities towards the bacterial membranes and mammalian cell membranes.[44]

In addition, there are also other factors that will affect the selectivity. It's well known that cholesterol is normally widely distributed in the mammalian cell membranes as a membrane stabilizing agent but absent in bacterial cell membranes (except when sequestered by H. pylori);[45] and the presence of these cholesterols will also generally reduce the activities of the antimicrobial peptides, due either to stabilization of the lipid bilayer or to interactions between cholesterol and the peptide. So the cholesterol in mammalian cells will protect the cells from attack by the antimicrobial peptides.[46]

Besides, the transmembrane potential is well known to affect peptide-lipid interactions.[47] There's an inside-negative transmembrane potential existing from the outer leaflet to the inner leaflet of the cell membranes and this inside-negative transmembrane potential will facilitate membrane permeabilization probably by facilitating the insertion of positively charged peptides into membranes. By comparison, the transmembrane potential of bacterial cells is more negative than that of normal mammalian cells, so bacterial membrane will be prone to be attacked by the positively charged antimicrobial peptides.

Similarly, it is also believed that increasing ionic strength,[46] which in general reduces the activity of most antimicrobial peptides, contributes partially to the selectivity of the antimicrobial peptides by weakening the electrostatic interactions required for the initial interaction.

Mechanism

The cell membranes of bacteria are rich in acidic phospholipids, such as phosphatidylglycerol and cardiolipin.[41] [48]

In contrast, the outer part of the membranes of plants and mammals is mainly composed of lipids without any net charges since most of the lipids with negatively charged headgroups are principally sequestered into the inner leaflet of the plasma membranes.[44] Thus in the case of mammalian cells, the outer surfaces of the membranes are usually made of zwitterionic phosphatidylcholine and sphingomyelin, even though a small portion of the membrane's outer surfaces contain some negatively charged gangliosides. Therefore, the hydrophobic interaction between the hydrophobic face of amphipathic antimicrobial peptides and the zwitterionic phospholipids on the cell surface of mammalian cell membranes plays a major role in the formation of peptide-cell binding.[49]

Dual polarisation interferometry has been used in vitro to study and quantify the association to headgroup, insertion into the bilayer, pore formation and eventual disruption of the membrane.[50] [51]

Control

A lot of effort has been put into controlling cell selectivity. For example, attempts have been made to modify and optimize the physicochemical parameters of the peptides to control the selectivities, including net charge, helicity, hydrophobicity per residue (H), hydrophobic moment (μ) and the angle subtended by the positively charged polar helix face (Φ).[47] Other mechanisms like the introduction of D-amino acids and fluorinated amino acids in the hydrophobic phase are believed to break the secondary structure and thus reduce hydrophobic interaction with mammalian cells. It has also been found that Pro→Nlys substitution in Pro-containing β-turn antimicrobial peptides was a promising strategy for the design of new small bacterial cell-selective antimicrobial peptides with intracellular mechanisms of action.[52] It has been suggested that direct attachment of magainin to the substrate surface decreased nonspecific cell binding and led to improved detection limit for bacterial cells such as Salmonella and E. coli.[53]

Bacterial resistance

Bacteria use various resistance strategies to avoid antimicrobial peptide killing.[54] S. aureus also modifies its anionic membranes via MprF with L-lysine, increasing the positive net charge.[54]

While these examples show that resistance can evolve naturally, there is increasing concern that using pharmaceutical copies of antimicrobial peptides can make resistance happen more often and faster. In some cases, resistance to these peptides used as a pharmaceutical to treat medical problems can lead to resistance, not only to the medical application of the peptides, but to the physiological function of those peptides.[63] [64]

The ‘Trojan Horse’ approach to solving this problem capitalizes on the innate need for iron by pathogens. “Smuggling” antimicrobials into the pathogen is accomplished by linking them to siderophores for transport. While simple in concept, it has taken many decades of work to accomplish the difficult hurdle of transporting antimicrobials across the cell membranes of pathogens. Lessons learned from the successes and failures of siderophore-conjugate drugs evaluated during the development of novel agents using the ‘Trojan horse’ approach have been reviewed.[65]

Examples

Antimicrobial peptides are produced by species across the tree of life, including:

Research has increased in recent years to develop artificially-engineered mimics of antimicrobial peptides such as SNAPPs, in part due to the prohibitive cost of producing naturally-derived AMPs.[70] An example of this is the facially cationic peptide C18G, which was designed from the C-terminal domain of human platelet factor IV.[71] Currently, the most widely used antimicrobial peptide is nisin; being the only FDA approved antimicrobial peptide, it is commonly used as an artificial preservative.[72]

Bioinformatics

Several bioinformatic databases exist to catalogue antimicrobial peptides. The (APD) is the original and model database for antimicrobial peptides (https://aps.unmc.edu). Based on the APD, other databases have also been built, including ADAM (A Database of Anti-Microbial peptides),[73] BioPD (Biologically active Peptide Database), CAMP (Collection of sequences and structures of antimicrobial peptides),[74] DBAASP (Database of Antimicrobial Activity and Structure of Peptides), DRAMP (Data Repository of Antimicrobial Peptides)Welcome To Dramp Database,[75] and LAMP (Linking AMPs).

The Antimicrobial peptide databases may be divided into two categories on the basis of the source of peptides it contains, as specific databases and general databases. These databases have various tools for antimicrobial peptides analysis and prediction. For example, the APD has a widely used calculation interface. It also provides links to many other tools. CAMP contains AMP prediction, feature calculator, BLAST search, ClustalW, VAST, PRATT, Helical wheel etc. In addition, ADAM allows users to search or browse through AMP sequence-structure relationships. Antimicrobial peptides often encompass a wide range of categories such as antifungal, antibacterial, and antituberculosis peptides.

[76] Provides an online platform for exploring antimicrobial peptides with functional activities and physicochemical properties on transcriptome and proteome data. is an online resource that addresses various topics such as annotations of antimicrobial peptides (AMPs) including sequence information, antimicrobial activities, post-translational modifications (PTMs), structural visualization, antimicrobial potency, target species with minimum inhibitory concentration (MIC), physicochemical properties, or AMP–protein interactions.

Tools such as PeptideRanker,[77] PeptideLocator,[78] and AntiMPmod[79] [80] allow for the prediction of antimicrobial peptides while others have been developed to predict antifungal and anti-Tuberculosis activities.[81] [82]

See also

External links

Notes and References

  1. Ageitos JM, Sánchez-Pérez A, Calo-Mata P, Villa TG . Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria . Biochemical Pharmacology . 133 . 6 . 117–138 . June 2017 . 27663838 . 10.1016/j.bcp.2016.09.018 .
  2. Reddy KV, Yedery RD, Aranha C . Antimicrobial peptides: premises and promises . International Journal of Antimicrobial Agents . 24 . 6 . 536–547 . December 2004 . 15555874 . 10.1016/j.ijantimicag.2004.09.005 .
  3. Yeaman MR, Yount NY . Mechanisms of antimicrobial peptide action and resistance . Pharmacological Reviews . 55 . 1 . 27–55 . March 2003 . 12615953 . 10.1124/pr.55.1.2 . 6731487 .
  4. Papagianni M . Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications . Biotechnology Advances . 21 . 6 . 465–499 . September 2003 . 14499150 . 10.1016/S0734-9750(03)00077-6 .
  5. Sitaram N, Nagaraj R . Host-defense antimicrobial peptides: importance of structure for activity . Current Pharmaceutical Design . 8 . 9 . 727–742 . 2002 . 11945168 . 10.2174/1381612023395358 .
  6. Dürr UH, Sudheendra US, Ramamoorthy A . LL-37, the only human member of the cathelicidin family of antimicrobial peptides . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1758 . 9 . 1408–1425 . September 2006 . 16716248 . 10.1016/j.bbamem.2006.03.030 . free .
  7. Dhople V, Krukemeyer A, Ramamoorthy A . The human beta-defensin-3, an antibacterial peptide with multiple biological functions . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1758 . 9 . 1499–1512 . September 2006 . 16978580 . 10.1016/j.bbamem.2006.07.007 . 36461159 .
  8. Hancock RE, Rozek A . Role of membranes in the activities of antimicrobial cationic peptides . FEMS Microbiology Letters . 206 . 2 . 143–149 . January 2002 . 11814654 . 10.1111/j.1574-6968.2002.tb11000.x . free .
  9. Varkey J, Singh S, Nagaraj R . Antibacterial activity of linear peptides spanning the carboxy-terminal beta-sheet domain of arthropod defensins . Peptides . 27 . 11 . 2614–2623 . November 2006 . 16914230 . 10.1016/j.peptides.2006.06.010 . 21104756 .
  10. Nguyen LT, Haney EF, Vogel HJ . The expanding scope of antimicrobial peptide structures and their modes of action . Trends in Biotechnology . 29 . 9 . 464–472 . September 2011 . 21680034 . 10.1016/j.tibtech.2011.05.001 .
  11. O'Driscoll NH, Labovitiadi O, Cushnie TP, Matthews KH, Mercer DK, Lamb AJ . Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application . Current Microbiology . 66 . 3 . 271–278 . March 2013 . 23183933 . 10.1007/s00284-012-0268-3 . 18671683 .
  12. Hein KZ, Takahashi H, Tsumori T, Yasui Y, Nanjoh Y, Toga T, Wu Z, Grötzinger J, Jung S, Wehkamp J, Schroeder BO, Schroeder JM, Morita E . 6 . Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide . Proceedings of the National Academy of Sciences of the United States of America . 112 . 42 . 13039–13044 . October 2015 . 26438863 . 4620902 . 10.1073/pnas.1511197112 . 2015PNAS..11213039H . free .
  13. Brogden KA . Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? . Nature Reviews. Microbiology . 3 . 3 . 238–250 . March 2005 . 15703760 . 10.1038/nrmicro1098 . 23625167 .
  14. Hirst DJ, Lee TH, Swann MJ, Unabia S, Park Y, Hahm KS, Aguilar MI . Effect of acyl chain structure and bilayer phase state on binding and penetration of a supported lipid bilayer by HPA3 . European Biophysics Journal . 40 . 4 . 503–514 . April 2011 . 21222117 . 10.1007/s00249-010-0664-1 . 22514308 .
  15. Lee TH, Heng C, Swann MJ, Gehman JD, Separovic F, Aguilar MI . Real-time quantitative analysis of lipid disordering by aurein 1.2 during membrane adsorption, destabilisation and lysis . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1798 . 10 . 1977–1986 . October 2010 . 20599687 . 10.1016/j.bbamem.2010.06.023 . free .
  16. Book: Turnidge JD, Bell JM . Lorian V . Susceptibility testing of Antimicrobials in liquid media . Antibiotics in Laboratory Medicine . 1996 . Williams and Wilkins . Baltimore, Md. . 978-0-683-05169-8 . 4th . 52–111 . National Committee of Laboratory Safety and Standards (NCLSS) .
  17. Wang CK, Shih LY, Chang KY . Large-Scale Analysis of Antimicrobial Activities in Relation to Amphipathicity and Charge Reveals Novel Characterization of Antimicrobial Peptides . Molecules . 22 . 11 . 2037 . November 2017 . 29165350 . 6150348 . 10.3390/molecules22112037 . free .
  18. Hunter HN, Fulton DB, Ganz T, Vogel HJ . The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis . The Journal of Biological Chemistry . 277 . 40 . 37597–37603 . October 2002 . 12138110 . 10.1074/jbc.M205305200 . free.
  19. Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Elder J, Sonis ST, Straube R, Donini O . 6 . Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study . Journal of Biotechnology . 239 . 115–125 . December 2016 . 27746305 . 10.1016/j.jbiotec.2016.10.010 . free .
  20. Guilhelmelli F, Vilela N, Albuquerque P, Derengowski L, Silva-Pereira I, Kyaw CM . Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance . Frontiers in Microbiology . 4 . 4 . 353 . December 2013 . 24367355 . 10.3389/fmicb.2013.00353. 3856679 . free .
  21. Sengupta . Durba . Leontiadou . Hari . Mark . Alan E. . Marrink . Siewert-Jan . 2008-10-01 . Toroidal pores formed by antimicrobial peptides show significant disorder . Biochimica et Biophysica Acta (BBA) - Biomembranes . en . 1778 . 10 . 2308–2317 . 10.1016/j.bbamem.2008.06.007 . 18602889 . 19387026 . 0005-2736. free .
  22. Hallock KJ, Lee DK, Ramamoorthy A . MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain . Biophysical Journal . 84 . 5 . 3052–3060 . May 2003 . 12719236 . 1302867 . 10.1016/S0006-3495(03)70031-9 . free . 2003BpJ....84.3052H .
  23. In particular, solid-state NMR studies have provided an atomic-level resolution explanation of membrane disruption by antimicrobial peptides.[22]
  24. Henzler Wildman KA, Lee DK, Ramamoorthy A . Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37 . Biochemistry . 42 . 21 . 6545–6558 . June 2003 . 12767238 . 10.1021/bi0273563 .
  25. Järvå M, Lay FT, Phan TK, Humble C, Poon IK, Bleackley MR, Anderson MA, Hulett MD, Kvansakul M . 6 . X-ray structure of a carpet-like antimicrobial defensin-phospholipid membrane disruption complex . En . Nature Communications . 9 . 1 . 1962 . May 2018 . 29773800 . 5958116 . 10.1038/s41467-018-04434-y . free . 2018NatCo...9.1962J .
  26. Poon IK, Baxter AA, Lay FT, Mills GD, Adda CG, Payne JA, Phan TK, Ryan GF, White JA, Veneer PK, van der Weerden NL, Anderson MA, Kvansakul M, Hulett MD . 6 . Phosphoinositide-mediated oligomerization of a defensin induces cell lysis . eLife . 3 . e01808 . April 2014 . 24692446 . 3968744 . 10.7554/elife.01808 . free .
  27. Järvå M, Phan TK, Lay FT, Caria S, Kvansakul M, Hulett MD . Human β-defensin 2 kills Candida albicans through phosphatidylinositol 4,5-bisphosphate-mediated membrane permeabilization . Science Advances . 4 . 7 . eaat0979 . July 2018 . 30050988 . 6059731 . 10.1126/sciadv.aat0979 . free . 2018SciA....4..979J .
  28. Balatti GE, Ambroggio EE, Fidelio GD, Martini MF, Pickholz M . Differential Interaction of Antimicrobial Peptides with Lipid Structures Studied by Coarse-Grained Molecular Dynamics Simulations . Molecules . 22 . 10 . 1775 . October 2017 . 29053635 . 6151434 . 10.3390/molecules22101775 . free .
  29. Gomes B, Augusto MT, Felício MR, Hollmann A, Franco OL, Gonçalves S, Santos NC . Designing improved active peptides for therapeutic approaches against infectious diseases . Biotechnology Advances . 36 . 2 . 415–429 . 9 January 2018 . 29330093 . 10.1016/j.biotechadv.2018.01.004 . 3873934 . 11336/98840 . free .
  30. Hanson MA, Lemaitre B . New insights on Drosophila antimicrobial peptide function in host defense and beyond . Current Opinion in Immunology . 62 . 22–30 . February 2020 . 31835066 . 10.1016/j.coi.2019.11.008 . free . 10871/133705 . free .
  31. Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ . Antimicrobial host defence peptides: functions and clinical potential . Nature Reviews. Drug Discovery . 19 . 5 . 311–332 . May 2020 . 32107480 . 10.1038/s41573-019-0058-8 . free . 211526624 . 20.500.11820/1ec38809-e8f2-4684-8bbb-e908ecb5c66e .
  32. Hoskin DW, Ramamoorthy A . Studies on anticancer activities of antimicrobial peptides . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1778 . 2 . 357–375 . February 2008 . 18078805 . 2238813 . 10.1016/j.bbamem.2007.11.008 .
  33. Parvy JP, Yu Y, Dostalova A, Kondo S, Kurjan A, Bulet P, Lemaître B, Vidal M, Cordero JB . 6 . The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila . eLife . 8 . July 2019 . 31358113 . 6667213 . 10.7554/eLife.45061 . free .
  34. Kalsy M, Tonk M, Hardt M, Dobrindt U, Zdybicka-Barabas A, Cytrynska M, Vilcinskas A, Mukherjee K . 6 . The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms . npj Biofilms and Microbiomes . 6 . 1 . 6 . February 2020 . 32051417 . 7016129 . 10.1038/s41522-020-0116-3 . free .
  35. Hassan M, Kjos M, Nes IF, Diep DB, Lotfipour F . Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance . Journal of Applied Microbiology . 113 . 4 . 723–736 . October 2012 . 22583565 . 10.1111/j.1365-2672.2012.05338.x . 19503463 .
  36. Kumaresan V, Bhatt P, Ganesh MR, Harikrishnan R, Arasu M, Al-Dhabi NA, Pasupuleti M, Marimuthu K, Arockiaraj J . 6 . A novel antimicrobial peptide derived from fish goose type lysozyme disrupts the membrane of Salmonella enterica . Molecular Immunology . 68 . 2 Pt B . 421–433 . December 2015 . 26477736 . 10.1016/j.molimm.2015.10.001 .
  37. Arasu A, Kumaresan V, Ganesh MR, Pasupuleti M, Arasu MV, Al-Dhabi NA, Arockiaraj J . Bactericidal activity of fish galectin 4 derived membrane-binding peptide tagged with oligotryptophan . Developmental and Comparative Immunology . 71 . 37–48 . June 2017 . 28126555 . 10.1016/j.dci.2017.01.019 . 22374102 .
  38. Arockiaraj J, Chaurasia MK, Kumaresan V, Palanisamy R, Harikrishnan R, Pasupuleti M, Kasi M . Macrobrachium rosenbergii mannose binding lectin: synthesis of MrMBL-N20 and MrMBL-C16 peptides and their antimicrobial characterization, bioinformatics and relative gene expression analysis . Fish & Shellfish Immunology . 43 . 2 . 364–374 . April 2015 . 25575476 . 10.1016/j.fsi.2014.12.036 .
  39. News: Somasekhar M . 24 April 2019. In Spiny anteater's milk could be an alternative to antibiotics. en. BusinessLine. Kasturi & Sons Ltd.. Chennai, India. limited. 17 January 2021.
  40. News: 25 April 2019. Egg-laying mammal's milk may help for novel antibiotics. en. Deccan Herald. The Printers Mysore. Press Trust of India. India. 17 January 2021.
  41. Matsuzaki K . Control of cell selectivity of antimicrobial peptides . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1788 . 8 . 1687–1692 . August 2009 . 18952049 . 10.1016/j.bbamem.2008.09.013 . Review article .
  42. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T . High concentration of beta-defensin-2 in oral squamous cell carcinoma . Anticancer Research . 22 . 4 . 2103–2107 . 2002 . 12174890 .
  43. Kida-Takaoka S, Yamaai T, Mizukawa N, Murakami J, Iida S . Surrounding cells affect the gene expression pattern of human beta-defensins in squamous cell carcinoma in vitro . Anticancer Research . 34 . 11 . 6443–6449 . November 2014 . 25368244 . 7 February 2019 .
  44. Hancock RE, Sahl HG . Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies . Nature Biotechnology . 24 . 12 . 1551–1557 . December 2006 . 17160061 . 10.1038/nbt1267 . 22384207 . Review article .
  45. Zhang L, Xie J . Biosynthesis, structure and biological function of cholesterol glucoside in Helicobacter pylori: A review . Medicine (Baltimore) . 102 . 36 . e34911 . September 2023 . 37682174 . 10489377 . 10.1097/MD.0000000000034911 .
  46. Zasloff M . Antimicrobial peptides of multicellular organisms . Nature . 415 . 6870 . 389–395 . January 2002 . 11807545 . 10.1038/415389a . 2002Natur.415..389Z . 205028607 . Review article .
  47. Matsuzaki K, Sugishita K, Fujii N, Miyajima K . Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2 . Biochemistry . 34 . 10 . 3423–3429 . March 1995 . 7533538 . 10.1021/bi00010a034 .
  48. Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ . 6 . Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp . International Journal of Antimicrobial Agents . 32 . 2 . 130–138 . August 2008 . 18586467 . 10.1016/j.ijantimicag.2008.04.003 .
  49. Tennessen JA . Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection . Journal of Evolutionary Biology . 18 . 6 . 1387–1394 . November 2005 . 16313451 . 10.1111/j.1420-9101.2005.00925.x . Review article . free .
  50. Yu L, Guo L, Ding JL, Ho B, Feng SS, Popplewell J, Swann M, Wohland T . 6 . Interaction of an artificial antimicrobial peptide with lipid membranes . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1788 . 2 . 333–344 . February 2009 . 19013127 . 10.1016/j.bbamem.2008.10.005 .
  51. Book: Lee TH, Hall K, Mechler A, Martin L, Popplewell J, Ronan G, Aguilar MI . Molecular Imaging and Orientational Changes of Antimicrobial Peptides in Membranes . Advances in Experimental Medicine and Biology . Peptides for Youth . 611 . 313–315 . 2009 . 19400207 . 10.1007/978-0-387-73657-0_140 . 2009peyo.book..313L . 978-0-387-73656-3 .
  52. Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY . 6 . Effects of Pro → peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide . Biochemistry . 45 . 43 . 13007–13017 . October 2006 . 17059217 . 10.1021/bi060487+ .
  53. Kulagina NV, Lassman ME, Ligler FS, Taitt CR . Antimicrobial peptides for detection of bacteria in biosensor assays . Analytical Chemistry . 77 . 19 . 6504–6508 . October 2005 . 16194120 . 10.1021/ac050639r .
  54. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F . Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides . The Journal of Biological Chemistry . 274 . 13 . 8405–8410 . March 1999 . 10085071 . 10.1074/jbc.274.13.8405 . free.
    • Some microorganisms alter net surface charges. Staphylococcus aureus transports D-alanine from the cytoplasm to the surface teichoic acid which reduces the net negative charge by introducing basic amino groups.[54]
  56. Campos MA, Vargas MA, Regueiro V, Llompart CM, Albertí S, Bengoechea JA . Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides . Infection and Immunity . 72 . 12 . 7107–7114 . December 2004 . 15557634 . 529140 . 10.1128/IAI.72.12.7107-7114.2004 . Weiser JN .
  57. China B, N'Guyen BT, de Bruyere M, Cornelis GR . Role of YadA in resistance of Yersinia enterocolitica to phagocytosis by human polymorphonuclear leukocytes . Infection and Immunity . 62 . 4 . 1275–1281 . April 1994 . 8132334 . 186269 . 10.1128/IAI.62.4.1275-1281.1994 .
  58. Shelton CL, Raffel FK, Beatty WL, Johnson SM, Mason KM . Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus . PLOS Pathogens . 7 . 11 . e1002360 . November 2011 . 22072973 . 3207918 . 10.1371/journal.ppat.1002360 . free .
  59. Nikaido H . Multidrug efflux pumps of gram-negative bacteria . Journal of Bacteriology . 178 . 20 . 5853–5859 . October 1996 . 8830678 . 178438 . 10.1128/jb.178.20.5853-5859.1996 .
  60. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA . The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases . The Journal of Biological Chemistry . 271 . 17 . 10079–10086 . April 1996 . 8626565 . 10.1074/jbc.271.17.10079 . free .
  61. Kulkarni HM, Swamy C, Jagannadham MV . Molecular characterization and functional analysis of outer membrane vesicles from the antarctic bacterium Pseudomonas syringae suggest a possible response to environmental conditions . Journal of Proteome Research . 13 . 3 . 1345–1358 . March 2014 . 24437924 . 10.1021/pr4009223 .
  62. Chua SL, Tan SY, Rybtke MT, Chen Y, Rice SA, Kjelleberg S, Tolker-Nielsen T, Yang L, Givskov M . 6 . Bis-(3'-5')-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosa . Antimicrobial Agents and Chemotherapy . 57 . 5 . 2066–2075 . May 2013 . 23403434 . 3632963 . 10.1128/AAC.02499-12 .
  63. Habets MG, Brockhurst MA . Therapeutic antimicrobial peptides may compromise natural immunity . Biology Letters . 8 . 3 . 416–418 . June 2012 . 22279153 . 3367763 . 10.1098/rsbl.2011.1203 .
  64. Bahar AA, Ren D . Antimicrobial peptides . Pharmaceuticals . 6 . 12 . 1543–1575 . November 2013 . 24287494 . 3873676 . 10.3390/ph6121543 . free .
  65. Book: Gumienna-Kontecka E, Carver PL . Sigel A, Freisinger E, Sigel RK, Carver PL . Essential Metals in Medicine:Therapeutic Use and Toxicity of Metal Ions in the Clinic. Metal Ions in Life Sciences . 19 . 2019 . de Gruyter GmbH. Berlin. 978-3-11-052691-2. 10.1515/9783110527872-013. 30855108. 181–202. Chapter 7. Building a Trojan Horse: Siderophore-Drug Conjugates for the Treatment of Infectious Diseases. 73727689 .
  66. Web site: Insect antimicrobial peptides OPM . Orientations of Proteins in Membranes database (OPM) .
  67. Szymanowski F, Balatti GE, Ambroggio E, Hugo AA, Martini MF, Fidelio GD, Gómez-Zavaglia A, Pickholz M, Pérez PF . 6 . Differential activity of lytic α-helical peptides on lactobacilli and lactobacilli-derived liposomes . Biochimica et Biophysica Acta (BBA) - Biomembranes . 1861 . 6 . 1069–1077 . June 2019 . 30878358 . 10.1016/j.bbamem.2019.03.004 . free .
  68. Web site: Amphibian antimicrobial peptides . Orientations of Proteins in Membranes database (OPM) .
  69. Yang M, Zhang C, Zhang X, Zhang MZ, Rottinghaus GE, Zhang S . Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges . BMC Microbiology . 16 . 210 . September 2016 . 1 . 27613063 . 5016922 . 10.1186/s12866-016-0828-y . free .
  70. Web site: Synthetic Mimics of Antimicrobial Peptides: A New Wave of Antibiotics . https://web.archive.org/web/20161028023510/http://www.chem.uga.edu/seminars/4702-synthetic-mimics-antimicrobial-peptides-new-wave-antibiotics . 28 October 2016 . dead . University of Georgia . Department of Chemistry . 9 February 2012 . 27 October 2016 . Niedermaier H .
  71. Kohn EM, Shirley DJ, Arotsky L, Picciano AM, Ridgway Z, Urban MW, Carone BR, Caputo GA . 6 . Role of Cationic Side Chains in the Antimicrobial Activity of C18G . Molecules . 23 . 2 . 329 . February 2018 . 29401708 . 6017431 . 10.3390/molecules23020329 . free .
  72. Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL . Biomedical applications of nisin . Journal of Applied Microbiology . 120 . 6 . 1449–1465 . June 2016 . 26678028 . 4866897 . 10.1111/jam.13033 .
  73. Lee HT, Lee CC, Yang JR, Lai JZ, Chang KY . A large-scale structural classification of antimicrobial peptides . BioMed Research International . 2015 . 475062 . February 2015 . 26000295 . 4426897 . 10.1155/2015/475062 . free .
  74. Waghu FH, Gopi L, Barai RS, Ramteke P, Nizami B, Idicula-Thomas S . CAMP: Collection of sequences and structures of antimicrobial peptides . Nucleic Acids Research . 42 . Database issue . D1154–D1158 . January 2014 . 24265220 . 3964954 . 10.1093/nar/gkt1157 .
  75. Shi GB, Kang XY, Dong FY, Liu YC, Zhu N . DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides . Nucleic Acids Research . 50 . Database issue . D488–D496 . January 2022 . 34390348 . 8728287 . 10.1093/nar/gkab651 .
  76. Jhong JH, Chi YH, Li WC, Lin TH, Huang KY, Lee TY . dbAMP: an integrated resource for exploring antimicrobial peptides with functional activities and physicochemical properties on transcriptome and proteome data . Nucleic Acids Research . 47 . D1 . D285–D297 . January 2019 . 30380085 . 6323920 . 10.1093/nar/gky1030 .
  77. Mooney C, Haslam NJ, Pollastri G, Shields DC . Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity . PLOS ONE . 7 . 10 . e45012 . 8 October 2012 . 23056189 . 3466233 . 10.1371/journal.pone.0045012 . free . 2012PLoSO...745012M .
  78. Mooney C, Haslam NJ, Holton TA, Pollastri G, Shields DC . PeptideLocator: prediction of bioactive peptides in protein sequences . Bioinformatics . 29 . 9 . 1120–1126 . May 2013 . 23505299 . 10.1093/bioinformatics/btt103 . free . 10197/10121 . free .
  79. Müller AT, Gabernet G, Hiss JA, Schneider G . modlAMP: Python for antimicrobial peptides . Bioinformatics . 33 . 17 . 2753–2755 . September 2017 . 28472272 . 10.1093/bioinformatics/btx285 . free . 20.500.11850/206770 . free .
  80. Agrawal P, Raghava GP . Prediction of Antimicrobial Potential of a Chemically Modified Peptide From Its Tertiary Structure . Frontiers in Microbiology . 9 . 2551 . 26 October 2018 . 30416494 . 6212470 . 10.3389/fmicb.2018.02551 . free .
  81. Agrawal P, Bhalla S, Chaudhary K, Kumar R, Sharma M, Raghava GP . In Silico Approach for Prediction of Antifungal Peptides . Frontiers in Microbiology . 9 . 323 . 26 February 2018 . 29535692 . 5834480 . 10.3389/fmicb.2018.00323 . free .
  82. Usmani SS, Bhalla S, Raghava GP . Prediction of Antitubercular Peptides From Sequence Information Using Ensemble Classifier and Hybrid Features . Frontiers in Pharmacology . 9 . 954 . 26 August 2018 . 30210341 . 6121089 . 10.3389/fphar.2018.00954 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Antimicrobial peptides".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.